The Effect of Pomegranate (Punica Granatum L.) Peel Compress Application on Pain and Physical Function Status
Pomegranate
1 other identifier
interventional
67
1 country
1
Brief Summary
Osteoarthritis is the most common type of arthritis among rheumatologic diseases. Complementary therapies are one of the effective methods for pain control. This study was planned as a randomized controlled experimental study. For this purpose, patients diagnosed with knee osteoarthritis who applied to the Orthopedics Outpatient Clinic will be included. It was calculated that the study would include at least 67 patients. The study will be collected using patient information form, descriptive characteristics form, Visual Analog Scale (VAS) and WOMAC osteoarthritis application scale. It was planned as a randomized controlled experimental study to evaluate the effect of pomegranate peel (P. granatum) compress application on pain and function status. The study was divided into 3 groups as Pomegranate (Punica granatum) peel compress, hot compress and control group. Pomegranate (Punica granatum) peel compress was applied 3 days a week for 3 weeks by turning the powder into porridge check.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 14, 2023
CompletedFirst Submitted
Initial submission to the registry
August 8, 2023
CompletedFirst Posted
Study publicly available on registry
September 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2023
CompletedSeptember 13, 2023
September 1, 2023
6 months
August 8, 2023
September 5, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Visual Analog Scale
A VAS consisting of a 10-centimeter horizontal line, anchored evenly by numbers from 0 to 10, was used to assess the patient's pain and willingness to repeat the procedure. The number 0 was identical to having no pain while the number 10 corresponded to maximal pain that can be experienced by the patient
The scale was filled in the baseline
WOMAC Osteoarthritis Index
The WOMAC index is composed of 24 items and 3 subdimensions (pain, stiffness, and physical function). The participants are asked to rate pain (5 questions), stiffness (2 questions), and difficulties encountered in physical functioning (17 questions) during the day (24 hours). The index is a 5-point Likert-type scale, where 0 is none, 1 mild, 2 moderate, 3 severe, and 4 very severe. Pain scores range from 0e20 points, stiffness scores from 0e8 points, and difficulties in physical function scores from 0e68 points. Higher scores indicate increased pain and stiffness, impairment in physical functioning, and higher levels of physical limitation.
The scale was filled in the baseline
Study Arms (3)
Pomegranate (P. granatum) peel compress group
EXPERIMENTAL36 g of pomegranate peel powder was given to the patient in a closed container. A teaspoon (approximately 2-3 g) of powder was mixed with water from the storage container and applied to the patient's knee by making a paste, and then the knee was wrapped with a bandage. It was kept for 20 minutes by placing a hot thermophore (approximately 40-45 C) on it. This application was carried out 3 days a week.
Hot compress
PLACEBO COMPARATORIn the hot compress group, the knee was wrapped with a bandage and the hot thermophor (approximately 40-45 °C) was placed on the knee. The hot thermoform was applied to the patient 3 days a week by keeping it for 20 minutes.
Control Group
NO INTERVENTIONPatients in the control group did not receive any additional intervention.
Interventions
Pomegranate (Punica granatum) peel compress was applied 3 days a week for 3 weeks by turning the powder into porridge check.
Eligibility Criteria
You may qualify if:
- Visual analog scale score of 3 and above,
- those aged 45 and over,
- Diagnosed with knee OA by a physician according to the criteria of the American - Rheumatology Association (ARD),
- pain lasting at least 1 month or longer,
- not included in any physical therapy program during the research period, a
- capable of answering research questions,
- agreeing to participate in the research by giving verbal and written consent
You may not qualify if:
- with a defined psychiatric illness,
- having vision and hearing problems,
- diagnosed with complex disease such as malignant,
- having a wound in the application area,
- with a diagnosed vascular disease,
- the patient's other inflammatory disease such as rheumatoid arthritis, gout, fibromyalgia
- who have had serious trauma or surgery in the last 6 months,
- who have received DMARDS or intra-articular steroid injection therapy in the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dilek Efe Arslan
Kayseri, Melikgazi, 38280, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
DİLEK EFE ARSLAN
ERCİYES UNİVERSİTY
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- ErciyesU
Study Record Dates
First Submitted
August 8, 2023
First Posted
September 13, 2023
Study Start
April 14, 2023
Primary Completion
September 30, 2023
Study Completion
October 15, 2023
Last Updated
September 13, 2023
Record last verified: 2023-09